Michela Flego

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A New Antibody-Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia.

A New Antibody-Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia.

Journal: Biomolecules

Published: October 24, 2024

MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.

MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 30, 2023

Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development.

Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development.

Journal: International reviews of immunology

Published: September 08, 2021

Isolation and preliminary characterization of a human 'phage display'-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding.

Isolation and preliminary characterization of a human 'phage display'-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding.

Journal: Human antibodies

Published: November 09, 2020

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity.

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity.

Journal: BMC biotechnology

Published: April 17, 2019

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.

Journal: International journal of nanomedicine

Published: March 20, 2019

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion.

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion.

Journal: BMC biotechnology

Published: February 20, 2019

Construction of Human Naïve Antibody Gene Libraries.

Construction of Human Naïve Antibody Gene Libraries.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 10, 2018

Design and construction of a new human naïve single-chain fragment variable antibody library, IORISS1.

Design and construction of a new human naïve single-chain fragment variable antibody library, IORISS1.

Journal: Journal of biotechnology

Published: December 09, 2015

Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system.

Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system.

Journal: Protein expression and purification

Published: August 06, 2013

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases.

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases.

Journal: BMC medicine

Published: June 21, 2012

Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells.

Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells.

Journal: BMC biotechnology

Published: November 10, 2006

Showing 1-12 of 12

Last Updated: 09/26/2026